|
Sign In to gain access to subscriptions and/or personal tools.
|
Neuropsychiatric manifestations in patients with systemic lupus erythematosus: Diagnostic and predictive value of longitudinal examination of anti-ribosomal P antibody
T. Watanabe
Department of Medicine () Niigata University School of Medicine
T. Sato
Department of Medicine () Niigata University School of Medicine
T. Uchiumi
Department of Biochemistry, Niigata University School of Medicine, 1-757 Asahimachi-Dori, Niigata 951, Japan
M. Arakawa
Department of Medicine () Niigata University School of Medicine
Anti-ribosomal P (anti-P) antibodies (IgG, IgA, IgM) were measured by an enzyme-linked immunosorbent assay (ELISA) in serial serum samples from the patients with systemic lupus erythematosus (SLE), and these clinical significance was investigated. Neuropsychi atric manifestations were observed in 24 of 144 patients with SLE. Twelve patients had lupus psychosis, nine convulsion or coma and three primary schizophrenia. In the group with lupus psychosis, serum C3 was significantly higher (p < 0.05) and anti-ds-DNA anti body was significantly lower (p < 0.05) than in the other patients. The titer of anti-P anti bodies was significantly higher in the group with lupus psychosis than that of the other patients. In a longitudinal study, IgA and IgM classes of anti-P antibody were elevated at the onset of psychosis. The titer decreased following a remission of psychosis. Therefore, the measurement of immunoglobulin classes of anti-P antibody will be useful for the diagnosis and follow-up of patients with lupus psychosis.
Key Words: SLE • neuropsychiatric manifestation • anti-P antibody • ELISA • longitudinal study
Lupus, Vol. 5, No. 3,
178-183 (1996)
DOI: 10.1177/096120339600500303
 CiteULike  Complore  Connotea  Del.icio.us  Digg  Reddit  Technorati  Twitter What's this?
This article has been cited by other articles:
|
|
|
|
 
T Ebert, J Chapman, and Y Shoenfeld
Anti-ribosomal P-protein and its role in psychiatric manifestations of systemic lupus erythematosus: myth or reality?
Lupus,
August 1, 2005;
14(8):
571 - 575.
[Abstract]
[PDF]
|
|
|
|
|
|
|
R. Gerli, L. Caponi, A. Tincani, R. Scorza, M. G. Sabbadini, M. G. Danieli, V. De Angelis, M. Cesarotti, M. Piccirilli, R. Quartesan, et al.
Clinical and serological associations of ribosomal P autoantibodies in systemic lupus erythematosus: prospective evaluation in a large cohort of Italian patients
Rheumatology,
December 1, 2002;
41(12):
1357 - 1366.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
L Massardo, P Burgos, M E Martinez, R Perez, M Calvo, J Barros, A Gonzalez, and S Jacobelli
Antiribosomal P protein antibodies in Chilean SLE patients: no association with renal disease
Lupus,
June 1, 2002;
11(6):
379 - 383.
[Abstract]
[PDF]
|
|
|
|
|
|
|
A Ghirardello, A Doria, S Zampieri, R Gerli, E Rapizzi, and P F Gambari
Anti-ribosomal P protein antibodies detected by immunoblotting in patients with connective tissue diseases: their specificity for SLE and association with IgG anticardiolipin antibodies
Ann Rheum Dis,
December 1, 2000;
59(12):
975 - 981.
[Abstract]
[Full Text]
|
|
|
|
|
|
|
G Sanna, M Piga, J W Terryberry, M T Peltz, S Giagheddu, L Satta, A Ahmed, A Cauli, C Montaldo, G Passiu, et al.
Central nervous system involvement in systemic lupus erythematosus: cerebral imaging and serological profile in patients with and without overt neuropsychiatric manifestations
Lupus,
October 1, 2000;
9(8):
573 - 583.
[Abstract]
[PDF]
|
|
|
|
|
|
|
W. Egner
The use of laboratory tests in the diagnosis of SLE
J. Clin. Pathol.,
June 1, 2000;
53(6):
424 - 432.
[Full Text]
[PDF]
|
|
|
|
|
|
|
G. Iverson
Are Antibodies to Ribosomal P Proteins a Clinically Useful Predictor of Neuropsychiatric Manifestations in Patients with Systemic Lupus Erythematosus?
Lupus,
December 1, 1996;
5(6):
634 - 635.
[PDF]
|
|
|
|
|
|
|
D. Mevorach and K. Elkon
Neuropsychiatric lupus: getting beyond the barrier of the brain
Lupus,
June 1, 1996;
5(3):
173 - 174.
[PDF]
|
|
|
|
|
